Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Dicks, M, Spencer, A, Edwards, N, Gilbert, S, Hill, S, Cottingham, MG
Μορφή:	Journal article
Έκδοση:	2011

Παρόμοια τεκμήρια

Uncovering the mechanisms of adenovirus vector immunogenicity
ανά: Dicks, M, κ.ά.
Έκδοση: (2013)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
ανά: Dicks, M, κ.ά.
Έκδοση: (2012)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
ανά: Matthew D J Dicks, κ.ά.
Έκδοση: (2012-01-01)

STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
ανά: Eriko Padron-Regalado, κ.ά.
Έκδοση: (2022-08-01)

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
ανά: Warimwe, G, κ.ά.
Έκδοση: (2013)

The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.
ανά: Dicks, M, κ.ά.
Έκδοση: (2015)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
ανά: Ewer (nee Russell), K, κ.ά.
Έκδοση: (2017)

Novel adenovirus vaccine vectors
ανά: Dicks, M
Έκδοση: (2013)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
ανά: Dicks, M, κ.ά.
Έκδοση: (2015)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
ανά: Katie Ewer, κ.ά.
Έκδοση: (2017-12-01)

Simian adenoviruses as vaccine vectors
ανά: Morris, S, κ.ά.
Έκδοση: (2016)

Simian adenoviruses as vaccine vectors
ανά: Morris, S, κ.ά.
Έκδοση: (2016)

Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass.
ανά: Alcock, R, κ.ά.
Έκδοση: (2010)

Adenoviral vectors as novel vaccines for influenza.
ανά: Coughlan, L, κ.ά.
Έκδοση: (2015)

Immunogenicity and cross-reactivity of rhesus adenoviral vectors
ανά: Iampietro, M, κ.ά.
Έκδοση: (2018)

Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
ανά: Lynda Coughlan
Έκδοση: (2020-05-01)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
ανά: Marta Ulaszewska, κ.ά.
Έκδοση: (2023-01-01)

MAIT cell activation augments adenovirus vector vaccine immunogenicity
ανά: Provine, N, κ.ά.
Έκδοση: (2021)

EVALUATION OF SIMIAN ADENOVIRAL VECTOR ADCH63 EXPRESSING MSP-1 AS A CANDIDATE BLOOD-STAGE MALARIA VACCINE
ανά: Goodman, A, κ.ά.
Έκδοση: (2009)

Development of novel vaccine vectors: Chimpanzee adenoviral vectors
ανά: Jingao Guo, κ.ά.
Έκδοση: (2018-07-01)

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
ανά: Reyes-Sandoval, A, κ.ά.
Έκδοση: (2008)

Adenovirus vector and mRNA vaccines: mechanisms regulating their immunogenicity
ανά: Provine, NM, κ.ά.
Έκδοση: (2022)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors
ανά: Cottingham, MG, κ.ά.
Έκδοση: (2011)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors.
ανά: Cottingham, MG, κ.ά.
Έκδοση: (2012)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity.
ανά: Reyes-Sandoval, A, κ.ά.
Έκδοση: (2012)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity
ανά: Reyes-Sandoval, A, κ.ά.
Έκδοση: (2012)

Correction: Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei
ανά: Reyes-Sandoval, A, κ.ά.
Έκδοση: (2011)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
ανά: Biswas, S, κ.ά.
Έκδοση: (2011)

Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.
ανά: Draper, S, κ.ά.
Έκδοση: (2013)

Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies
ανά: Folegatti, P, κ.ά.
Έκδοση: (2021)

Using multivalent adenoviral vectors for HIV vaccination.
ανά: Linlin Gu, κ.ά.
Έκδοση: (2013-01-01)

An Adenoviral Vector Based Vaccine for Rhodococcus equi.
ανά: Carla Giles, κ.ά.
Έκδοση: (2016-01-01)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
ανά: Folegatti, P, κ.ά.
Έκδοση: (2019)

Immunogenicity of a pre-erythrocytic-stage malaria insert ME-trap encoded by novel simian adenoviral vectors
ανά: Reyes-Sandoval, A, κ.ά.
Έκδοση: (2005)

Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies
ανά: Pedro M. Folegatti, κ.ά.
Έκδοση: (2021-03-01)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
ανά: Pedro M. Folegatti, κ.ά.
Έκδοση: (2019-05-01)

Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in Mice.
ανά: Bruna de Andrade Pereira, κ.ά.
Έκδοση: (2015-01-01)

Pandemic-response adenoviral vector and RNA vaccine manufacturing
ανά: Zoltán Kis, κ.ά.
Έκδοση: (2022-03-01)

The use of adenoviral vectors in gene therapy and vaccine approaches
ανά: Natália Meneses Araújo, κ.ά.
Έκδοση: (2022-10-01)

Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
ανά: Ekramy E. Sayedahmed, κ.ά.
Έκδοση: (2020-10-01)